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Abstract
Background: The bone-bone marrow interface is an area of the bone marrow microenvironment in which both bone
remodeling cells, osteoblasts and osteoclasts, and hematopoietic cells are anatomically juxtaposed. The close proximity of
these cells naturally suggests that they interact with one another, but these interactions are just beginning to be
characterized.
Methodology/Principal Findings: An Id1
2/2 mouse model was used to assess the role of Id1 in the bone marrow
microenvironment. Micro-computed tomography and fracture tests showed that Id1
2/2 mice have reduced bone mass and
increased bone fragility, consistent with an osteoporotic phenotype. Osteoclastogenesis and pit formation assays revealed
that loss of Id1 increased osteoclast differentiation and resorption activity, both in vivo and in vitro, suggesting a cell
autonomous role for Id1 as a negative regulator of osteoclast differentiation. Examination by flow cytometry of the
hematopoietic compartment of Id1
2/2 mice showed an increase in myeloid differentiation. Additionally, we found
increased expression of osteoclast genes, TRAP, Oscar, and CTSK in the Id1
2/2 bone marrow microenvironment. Lastly,
transplantation of wild-type bone marrow into Id1
2/2 mice repressed TRAP, Oscar, and CTSK expression and activity and
rescued the hematopoietic and bone phenotype in these mice.
Conclusions/Significance: In conclusion, we demonstrate an osteoporotic phenotype in Id1
2/2 mice and a mechanism for
Id1 transcriptional control of osteoclast-associated genes. Our results identify Id1 as a principal player responsible for the
dynamic cross-talk between bone and bone marrow hematopoietic cells.
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Introduction
Hematopoietic stem and progenitor cell (HSPC) self-renewal,
proliferation, and differentiation are tightly regulated processes
that depend on the microenvironment in which they reside [1,2].
This microenvironment is located in the bone marrow (BM) where
hematopoietic and bone remodeling cells, osteoblasts and
osteoclasts, are anatomically juxtaposed. Due to the close
proximity of these cells, it is reasonable to hypothesize that these
hematopoietic and bone cells communicate with and/or regulate
one another. However, the complex microenvironmental interac-
tions and the molecular pathways that govern these connections
occurring at this bone-bone marrow interface are still not well
understood.
At the bone surface, the dynamic process of bone remodeling
involves the constant interaction between bone-forming osteoblasts
and bone-resorbing osteoclasts [3–7]. While the roles of osteoblasts
and osteoclasts in bone remodeling have been well established,
recent studies have demonstrated that these cells are also crucial
components of the hematopoietic stem cell (HSC) niche.
Accumulating evidence suggests that osteoblasts enforce the
quiescence of HSCs, while osteoclasts induce hematopoietic
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7955activity. In particular, osteoblasts have been shown to physically
anchor HSCs to the endosteal surface of the trabecular regions of
the bone, thereby keeping them in an undifferentiated and
quiescent state [8–10]. Conversely, osteoclasts secrete bone-
resorbing enzymes, such as cathepsin K (CTSK), which promote
mobilization of HSCs from their quiescent state. This process
involves the cleavage of cytokines, such as stem cell factor (SCF),
that are responsible for HSC anchorage to the niche [11,12].
Thus, the balance between osteoblastic and osteoclastic activity
not only dictates healthy bone volume but also contributes to
maintaining hematopoietic homeostasis.
Although a great deal of progress has been made in defining the
BM microenvironment, the molecular regulators involved, their
interactions, and how they affect bone remodeling, hematopoiesis,
and cell fate decisions are largely unknown. Here, we report a new
role for the inhibitor of differentiation (Id1) gene in bone
remodeling and maintenance of the BM microenvironment. Id1
is one of four proteins in a family of transcriptional regulators that
all function by inhibiting basic helix-loop-helix (bHLH) transcrip-
tion factors from binding DNA [13,14]. Id proteins have a helix-
loop-helix domain that allows them to dimerize with bHLH
transcription factors, but lack a DNA-binding domain. As a result,
Id-bHLH transcription factor heterodimers cannot bind to DNA,
leading to the disruption of the events mediating the cellular
differentiation and proliferation of a variety of different cell types.
In this study, we report several lines of evidence that Id1 is a
critical regulatorof bone and BMhomeostasis. In particular, Id1
2/2
mice exhibited an osteoporotic phenotype, with significantly
reduced bone mineral content and density. This is a novel finding,
as Id1 has not been previously linked to osteoporosis. We also show
that the expression of genes necessary for osteoclast maturation,
such as CTSK, TRAP, and Oscar are upregulated in osteoclasts
derived from Id1
2/2 mice and repressed in osteoclasts overex-
pressing Id1, suggesting that Id1 is a master regulator of a set of
genes required for osteoclast function and bone resorption.
Examination of the hematopoietic compartment of Id1
2/2 mice
revealed an increase in myeloid differentiation and HSPC
proliferation. Thus, in the absence of Id1, the HSPC pool is likely
depleted by the increased flux towards myeloid differentiation,
resulting in osteoclast-driven changes to the BM microenviron-
ment. Results from this study will shed light on the molecular cues
at the bone-bone marrow interface that regulate both bone and
BM homeostasis. Moreover, Id1 may potentially be a novel
therapeutic target for the treatment of skeletal disorders.
Results
Id1
2/2 Mice Exhibit an Osteoporotic Phenotype
To assess the effect of loss of Id1 on skeletal structure and
function, we analyzed the bones of Id1
2/2 mice. Id1
2/2 mice
were born at the expected mendelian frequency and showed no
obvious abnormalities. We observed that Id1
2/2 mice were
slightly, but significantly smaller than wild-type littermates
(Figure 1A, Figure S1A). Morphological analysis of the skeleton
revealed a phenotype that previously has not been reported in
these mice. Microradiographs showed a marked decrease in the
radiodensity of Id1
2/2 long bones, a feature that was most
pronounced in regions of rapid longitudinal growth, such as the
distal femur and the proximal tibia (Figure 1B). Three-dimensional
microstructural analysis using micro-computed tomography (mi-
cro-CT) confirmed that loss of Id1 resulted in a significant
reduction in bone mass (Figure 1C). Furthermore, this analysis
revealed significant decreases in bone volume fraction, bone
mineral content, bone mineral density (BMD), trabecular
thickness, and marrow area (Table 1, Figure S1B). To determine
whether the differences in the microstructural properties influ-
enced the mechanical strength of the bone, we performed a three-
point bending test on the femurs of wild-type and Id1
2/2 mice.
The bending moment and bending rigidity were significantly
decreased in Id1
2/2 mice (Figure 1D), indicating that the bones of
Id1
2/2 mice are weaker and more prone to fractures as compared
to wild-type bones. Together, these results demonstrate an
osteoporotic phenotype in Id1
2/2 mice, characterized by low
bone mass and micro-architectural deterioration of bone tissue,
with a resultant increase in bone fragility and susceptibility to
fracture.
Osteoblast Development and Function Appear Normal in
Id1
2/2 Mice
Since proper bone remodeling is determined by a delicate
balance between the bone-forming osteoblasts and the bone-
resorbing osteoclasts, the observed osteoporosis in Id1
2/2 mice
could be a consequence of decreased osteoblast activity, increased
osteoclast activity, or both. We first examined whether the loss of
Id1 affects osteoblast development and function. Staining for
osteoblast marker, pro-collagen I, on femur sections showed
normal ratios of osteoblast numbers to bone surface in Id1
2/2
mice as compared to wild-type littermates (Figure 2A). Double
tetracycline labeling also showed normal mineral apposition rates
(Figure 2B), indicating normal osteoblast activity in vivo.I n
addition, the expression of osteoblast-associated cytokines receptor
activator of nuclear factor-kB ligand (RANKL), osteoprotegerin
(OPG), and stromal cell-derived factor 1 (SDF-1) was not altered
in Id1
2/2 and wild-type bones (Figure S2). Thus, the decrease in
bone mass in Id1
2/2 mice did not appear to be due to defects in
osteoblast number or function.
Id1 Negatively Regulates Osteoclastogenesis In Vivo and
InVitro
Next, we examined whether Id1 affects osteoclast differentiation
and function. Enzyme histochemistry for osteoclast marker,
tartrate-resistant acid phosphatase (TRAP), on femur sections
showed significantly increased osteoclast numbers in Id1
2/2 long
bones (Figure 2C). To determine whether increased osteoclast
differentiation could be caused by a cell-autonomous role for Id1in
the osteoclast lineage, BM mononuclear cells were isolated and
differentiated in vitro. In support of our in vivo findings,
differentiation of Id1
2/2 BM cells gave rise to 1.6 fold more
TRAP-positive osteoclasts as compared to wild-type cells
(Figure 2D). Moreover, in vitro resorption assays showed that
Id1
2/2 osteoclasts were functionally active (Figure 2E). Thus, our
in vivo and in vitro data suggest that Id1 has a cell-intrinsic role as a
negative regulator of osteoclast differentiation.
Myeloid Differentiation Is Enhanced in Id1
2/2 Mice
Whereas osteoblasts arise from mesenchymal stem cells,
osteoclasts differentiate from hematopoietic monocyte/macro-
phage precursors of the myeloid lineage. Consequently, the
observed osteoporotic bone phenotype and increased osteoclasto-
genesis in Id1
2/2 mice could be due to altered homeostasis of
myeloid precursor cells. To explore this possibility, we analyzed
various subsets of committed myeloid progenitor cells in the BM,
represented by the lineage negative, c-kit
+ and sca-1
2, (LKS
2)
progenitor population. The common myeloid progenitor (CMP)
population, the most immature of the myeloid progenitor cells,
was decreased in Id1
2/2 mice, while the more mature megakaryo-
erythrocyte progenitor (MEP) subset was significantly expanded
Id1 Regulates Bone Homeostasis
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subpopulations showed a higher fraction of CD11b
+ monocytes in
the BM (Figure 3B) and a higher fraction of monocytes and
neutrophils in the peripheral blood of Id1
2/2 mice compared to
wild-type littermates (Figure 3C, Table S1). Thus, in Id1-deficient
mice, myeloid differentiation is increased, indicating that Id1
Figure 1. Skeletal phenotype of Id1
2/2 and wild-type mice at 6 weeks of age. (A) Photograph of a representative Id1
2/2 and wild-type
mouse. (B) X-ray microradiographs of hindlimbs. White arrows indicate trabecular bone regions. (C) Representative micro-CT images of the femoral
trabecular and cortical regions in wild-type and Id1
2/2 mice. (D) Three-point bending tests for evaluating the mechanical strength of femurs from
wild-type (n=8) and Id1
2/2 (n=8) mice. The parameters measured include the bending moment and the bending rigidity (*P,0.05, **P,0.01). Error
bars represent 6S.E.M.
doi:10.1371/journal.pone.0007955.g001
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tiated state. These findings are consistent with the previously
suggested role of Id1 in restraining both myeloid [15] and
erythroid [16] differentiation.
To determine whether the loss of Id1 alters the kinetics of myeloid
differentiation, we challenged Id1
2/2 and wild-type mice with a
single, low dose of 5-fluorouracil (5-FU), a myeloablative drug that
mobilizes stem cells from their quiescent state to reconstitute the
hematopoietic system (Figure 3D). We observed an increase in total
numbers of white blood cells at day 15 after 5-FU administration due
to an increase in both neutrophils and monocytes (Figure 3E),
demonstrating that Id1 also regulates myeloid differentiation during
hematopoietic recovery after myeloablation.
Proliferation of Id1
2/2 LSK Cells Is Enhanced In Vivo, but
Not In Vitro
After a single, low dose injection of 5-FU, hematopoietic recovery
in Id1
2/2 mice was delayed by 3 days, as compared to wild-type
littermatecontrols(Figure3D).Totestwhetherthisdelaywasdueto
increased cell cycling of Id1
2/2 progenitor cells, we performed
BrdU labeling at steady state and during reconstitution following
myeloablation. We observed a significant increase in the number of
BrdU-labeled, Lin
2 sca-1
+c-kit
+ (LSK) cells both at steady state
(Figure 4A) and during hematopoietic recovery (Figure 4B),
suggesting that a higher fraction of Id1 deficient LSK cells enter
the cell cycle as compared to wild-type cells. In contrast, when we
isolated and cultured the LSK cells in vitro, Id1
2/2 and wild-type
cells proliferated at the same rate (Figure 4C), signifying that Id1
might indirectly affect the proliferation of LSK cells via factors
secreted in the BM microenvironment.
To investigate whether the enhanced proliferation status of LSK
cells in Id1
2/2 mice would lead to premature exhaustion of
HSPCs after continuous myeloablative stress, we treated wild-type
and Id1
2/2 mice weekly with 5-FU. We found that the survival
rate was much lower in Id1
2/2 mice than in wild-type controls
(Figure 4D). Analysis of blood and BM from both Id1
2/2 and
wild-type mice severely affected by the 5-FU treatment showed a
complete absence of myeloid cells, low hemoglobin/RBC counts,
and low platelet counts (data not shown). These observations
suggested that both Id1
2/2 and wild-type mice succumbed to BM
failure, but that Id1
2/2 mice did so at a faster rate. Thus, Id1
deficient LSK cells showed altered proliferation kinetics with more
progenitor cells entering cell cycle both at steady state and under
conditions that lead to hematopoietic stress.
Intrinsic and Extrinsic Mechanisms Operate in the Bone
Marrow Microenvironment
Recently, a number of studies have highlighted the importance
of both intrinsic and extrinsic cues within the BM to maintain
effective control over HSPCs [17,18]. To explore the relative
contributions of these intrinsic and extrinsic signals in the BM, we
performed a series of BM transplant experiments in which we
subjected the mice to weekly injections of 5-FU. Wild-type BM
was transplanted into Id1
2/2 mice and Id1
2/2 BM was
transplanted into wild-type mice. As a control, wild-type BM
was transplanted into wild-type mice and Id1
2/2 BM was
transplanted into Id1
2/2 mice. For the purpose of following
engraftment by Y chromosome specific PCR, all recipient mice
were female and all donor mice were male. Six weeks after
transplantation, these mice were treated weekly with 5-FU and
their survival was monitored (Figure 5A). If Id1 is exclusively an
intrinsic regulator, we would expect a complete rescue of the
hematopoietic phenotype, such that Id1
2/2 mice transplanted
with wild-type BM would have the same survival rate as wild-type
mice transplanted with wild-type BM. However, the hematopoi-
etic rescue that we observed was partial. Transplantation of wild-
type BM into Id1
2/2 mice significantly increased their survival,
but not to the level of wild-type mice transplanted with wild-type
BM. Similarly, transplantation of Id1
2/2 BM into wild-type mice
significantly reduced their survival, but not to the same level as
Id1
2/2 mice transplanted with Id1
2/2 BM.
To investigate whether BM transplantation could have a similar
effect in rescuing the bone phenotype seen in Id1
2/2 mice, we
performed the same BM transplants as described above and
analyzed the bone properties by micro-CT. To allow sufficient
time for bone turnover to occur, we waited 3.5 months post-
transplantation before sacrifice. Micro-CT analysis showed that
transplantation of wild-type BM into wild-type mice and Id1
2/2
BM into Id1
2/2 mice recapitulated the same bone phenotype seen
in wild-type and Id1
2/2 mice, respectively. Id1
2/2 mice
transplanted with Id1
2/2 BM had significantly reduced BMD
and trabecular bone compared with wild-type mice transplanted
with wild-type BM (Figure 5B). Following the same reasoning as
above, we would expect that if Id1 is exclusively an intrinsic
regulator, we would see a complete rescue of the bone phenotype,
such that Id1
2/2 mice transplanted with wild-type BM would have
the same bone microstructural properties as wild-type mice
transplanted with wild-type BM. However, once again, the rescue
that we observed was partial. Transplantation of wild-type BM
into Id1
2/2 mice significantly increased their BMD and trabecular
bone, but not to the level of wild-type mice transplanted with wild-
type BM. Correspondingly, transplantation of Id1
2/2 BM into
wild-type mice significantly reduced their BMD and trabecular
bone, but not to the same level as Id1
2/2 mice transplanted
with Id1
2/2 BM. Together, these results show that the loss of
Id1 impacts both intrinsic and extrinsic signals in the BM
microenvironment.
To rule out the possibility that the partial rescue of
hematopoietic and bone phenotypes in these mice was not due
to post transplant donor/host chimerism, we performed qPCR for
the Y chromosome specific, sex determining region (SRY) gene.
Complete donor chimerism is often defined as the detection of
greater than 95% donor DNA [19]. By this definition, all of the
mice we transplanted achieved complete donor hematopoietic
chimerism (Figure S3), indicating the sustained engraftment of
donor-derived cells. Therefore, it is unlikely that autologous
hematopoiesis had any impact on the partial rescue of phenotypes
in these mice.
Next, we examined the microenvironment of Id1
2/2 and wild-
type mice to explore differences that might be responsible for the
observed phenotypes. Recently, it was shown that CTSK, a
proteolytic enzyme secreted by osteoclasts, can cleave cytokines
that regulate stem cell proliferation, survival, and mobilization
Table 1. Characteristics of femurs in 6-week old wild-type
and Id1
2/2 mice.
WT (n=8) Id1
2/2 (n=8) p-value
Bone Volume Fraction 0.19960.024 0.13560.021 ,0.001
Bone Mineral Content (mg) 1.51460.176 1.01560.173 ,0.001
Bone Mineral Density (mg/cc) 665.8616.25 578.1619.37 ,0.01
Trabecular Thickness (mm) 0.03560.003 0.03160.003 ,0.05
Marrow Area (mm2) 1.02260.065 0.55260.019 ,0.001
doi:10.1371/journal.pone.0007955.t001
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protein level in the BM of Id1
2/2 mice as compared to wild-type
littermates (Figure 5C,D). Expression levels of other cathepsins
remained unchanged (Figure S4). One of the cytokines that can be
cleaved by CTSK is SCF, which is involved in anchoring stem
cells to the niche. Accordingly, we found elevated levels of SCF in
Figure 2. Enhanced osteoclast differentiation in Id1
2/2 mice. (A) Femoral sections were stained for Procollagen Type I and the number of
osteoblasts per unit surface area was counted. (B) The mineral apposition rate was determined by double tetracycline labeling. (C) Enzyme
histochemistry staining for TRAP on femoral sections (200X). Arrowheads indicate TRAP
+ osteoclasts stained in red. (D) BM cells were cultured in the
presence of M-CSF and RANKL for 3 days and then subjected to TRAP staining (400X). (E) BM cells were plated on a BD BioCoat Osteologic slide and
cultured in the presence of M-CSF and RANKL for 10 days. The area resorbed was visualized by von Kossa staining (40X). (A–E) *P,0.05, **P,0.01;
n=5. Error bars represent 6S.E.M.
doi:10.1371/journal.pone.0007955.g002
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PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e7955Figure 3. Enhanced myeloid differentiation in Id1
2/2 mice. (A) Representative flow-cytometric profiles of myeloid progenitor populations
(CMP, GMP, MEP) in wild-type and Id1
2/2 BM (n=6). (B) Monocytes in the BM were measured by flow cytometry using antibodies against CD11b and
CD45 (n=8). (C) Monocytes in the blood were measured by a complete blood count test (n=40). (D) White blood cell (WBC) counts in wild-type and
Id1
2/2 mice during hematopoietic challenge. Mice were given a single injection of 5-FU and bled every 3 days (n=5). (E) Monocyte and neutrophil
counts measured 15 days after 5-FU injection (n=5). (A–E) *P,0.05, **P,0.01, ***P,0.001. Error bars represent 6S.E.M.
doi:10.1371/journal.pone.0007955.g003
Id1 Regulates Bone Homeostasis
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by CTSK in the BM.
A Mechanism for Id1 Function in Bone and the Bone
Marrow Microenvironment
Our findings suggested that Id1 is critical for proper function of
the BM microenvironment and that loss of Id1 impacts HSPC
homeostasis via osteoclast-induced modifications in the bone.
Thus, we hypothesized that Id1 acts to inhibit differentiation of
both myeloid cells and osteoclasts, thereby keeping HSPCs
quiescent and in the BM (Figure S5). In support of this model,
we observed that osteoclast differentiation was increased in the
absence of Id1, leading to increased secretion of CTSK. As a
result, SCF cleavage by CTSK released soluble SCF into the
circulation and mobilized HSPCs out of the BM.
Since Id proteins are known to negatively regulate bHLH
transcription factor function, we hypothesized that Id1 interacts
with specific bHLH transcription factors to inhibit osteoclast
differentiation. Association between Id proteins and Mitf, a bHLH
transcription factor that targets genes such as CTSK, TRAP, and
osteoclast associated receptor (Oscar), has been demonstrated in
vitro [20]. During osteoclast differentiation, Mitf has been shown to
cooperate with other transcription factors, PU.1 and nuclear factor
of activated T cells 1 (NFATc1), to synergistically induce
expression of CTSK, TRAP, and Oscar [21–24]. In addition, a
positive feedback loop has been described between Oscar and
NFATc1, such that increased Oscar expression leads to increased
NFATc1 expression [25]. To investigate the role of Id1 in
transcriptional regulation of these osteoclast-associated genes, we
performed qPCR for CTSK, TRAP, Oscar, and NFATc1 in BM
isolated from Id1
2/2 and wild-type mice. In the absence of Id1,
these genes were significantly upregulated (Figure 6A), suggesting
that the loss of Id1 may allow increased binding of Mitf to PU.1
and NFATc1, subsequently resulting in increased expression of
target genes.
To explore this further, we transplanted lethally irradiated
Id1
2/2 mice with Id1
2/2 BM that was transduced with a
lentivirus vector overexpressing Id1 (Figure S6A, B). In these
transplanted mice, the genetic expression profile was reversed.
CTSK, TRAP, Oscar, and NFATc1 expression were significantly
downregulated in mice overexpressing Id1, as compared to mice
receiving the empty vector control (Figure 6B). Furthermore,
overexpression of Id1 in the BM of transplanted mice led to
decreased plasma levels of SCF (Figure 6C) and the restoration of
BM myeloid progenitor cell populations (Figure 6D).
Finally, we assessed whether phenotypic effects due to the loss of
Id1 could be reversed by abrogating CTSK activity. We
transplanted lethally irradiated Id1
2/2 mice with Id1
2/2 BM
that was transduced with a lentivirus vector containing a shRNA
targeted against CTSK (shCTSK) (Figure S7A). A shRNA
targeted against GFP (shGFP) was used as a control. To allow
sufficient time for bone turnover to occur, we performed micro-
CT on the bones of these mice 3.5 months after transplantation.
Mice transplanted with BM containing shCTSK had increased
bone volume fraction, trabecular number and thickness (Figure 6E,
Table S2, Figure S7B). In comparison, control mice exhibited a
severely reduced and more separated trabecular bone network,
similar to that of Id1
2/2 mice. Hence, inhibition of CTSK activity
was able to restore trabecular bone in Id1
2/2 mice. Overall, our
results support a model wherein Id1 interacts with bHLH
transcription factor Mitf to inhibit transcriptional activation of
osteoclast-associated genes, subsequently leading to regulation of
bone remodeling and the BM microenvironment.
Discussion
The roles for Id1 in differentiation, cell growth, senescence,
angiogenesis, and tumorigenesis have been extensively studied
[14,26–29]. Yet, how Id1 deficiency contributes to aging-
associated phenotypes, such as osteoporosis, has not been well
characterized. Previous studies have indicated that Id proteins
likely inhibit osteoclast differentiation from BM monocyte cells
grown in vitro [20]. However, the present study is the first to
demonstrate the direct correlation between Id1 and bone growth
in an in vivo animal model. Several novel findings have been
generated from this study. First, Id1
2/2 mice exhibited osteopo-
rosis due to increased osteoclast differentiation, a phenotype that
has not been previously described in these mice. Second, the
osteoporotic phenotype was associated with a reduction in the
Figure 4. Enhanced proliferation of LSK cells in Id1
2/2 mice. (A)
In vivo proliferation of LSK cells, at steady state, assessed by flow
cytometry for the percentage of BrdU
+ LSK cells (*P,0.05; n=5). (B) In
vivo proliferation of LSK cells from mice challenged with a single
injection of 5-FU. Flow cytometry was performed 15 days post 5-FU to
evaluate the percentage of BrdU
+ LSK cells (*P,0.05; n=7). (C) In vitro
proliferation of sorted LSK cells in response to cytokine stimulation
(n=3). (D) Survival over time of wild-type and Id1
2/2 mice treated with
weekly injections of 5-FU (P=0.013; n=10). Error bars represent 6S.E.M.
doi:10.1371/journal.pone.0007955.g004
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PLoS ONE | www.plosone.org 7 November 2009 | Volume 4 | Issue 11 | e7955Figure 5. Loss of Id1 alters extrinsic niche factors. (A) Survival over time of BM transplanted mice treated with weekly injections of 5-FU.
Lethally irradiated wild-type and Id1
2/2 mice were transplanted with either wild-type or Id1
2/2 BM. After 6 weeks to allow for hematopoietic
reconstitution, the mice were injected weekly with 5-FU and their survival was monitored (n=10). (B) Representative micro-CT images of the femoral
distal trabecular region and bone mineral density measurements in BM transplanted mice (**P,0.01, ***P,0.001; n=5). (C) CTSK staining of femoral
sections (400X). Arrowheads indicate CTSK
+ osteoclasts stained in brown (**P,0.01; n=5). (D) Level of expression of CTSK in the BM of wild-type and
Id1
2/2 mice (**P,0.01; n=8). (E) SCF levels in plasma assayed by ELISA (***P,0.001; n=8). Error bars represent 6S.E.M.
doi:10.1371/journal.pone.0007955.g005
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PLoS ONE | www.plosone.org 8 November 2009 | Volume 4 | Issue 11 | e7955Figure 6. A proposed mechanism for Id1 function in the BM microenvironment. (A) Expression of osteoclast-associated genes, TRAP, Oscar,
and NFATc1 in the BM of wild-type and Id1
2/2 mice (n=6). (B) Expression of osteoclast-associated genes from the BM of transplanted mice (n=6).
Lin
2 BM cells from Id1
2/2 mice were transduced with lentivirus containing PGEW-Id1 or PGEW-empty vector overnight and transplanted into Id1
2/2
mice. After 8 weeks, the mice were sacrificed and BM from the femur was collected for qPCR analysis. (C) SCF levels in plasma assayed by ELISA. (D)
Representative flow-cytometric profiles of myeloid progenitor populations (CMP, GMP, MEP) in mice transplanted with PGEW-Id1 or PGEW-empty BM
(n=6). (E) Representative micro-CT images of the femoral distal trabecular region in Id1
2/2 mice transplanted with BM containing a shRNA targeted
against CTSK or GFP. (A-D) *P,0.05, **P,0.01, ***P,0.001. Error bars represent 6S.E.M.
doi:10.1371/journal.pone.0007955.g006
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myeloid differentiation. Id1 impact on myeloid and osteoclast cell
numbers and their shared microenvironment can help explain the
functional significance of the drive toward the myeloid compart-
ment, as seen in our results, as well as others [15,30]. Thus, the
Id1
2/2 mouse represents a model that simulates the bone and BM
features seen in an aged host. Disruption of normal osteoclast
function via the loss of Id1 had profound effects on the behavior
and activity of cells in the BM microenvironment. These
observations demonstrate that bone cells provide critical regula-
tory cues to the hematopoietic system, confirming that cross-talk
between these different cell types at the bone-bone marrow
interface does indeed occur.
The BM microenvironment is a specialized region of the bone
responsible for a host of homeostatic functions, including
maintenance of stem cell number, protecting stem and progenitor
cells from exhaustion over the lifetime of an organism, and
providing cues that dictate the self-renewal or differentiation of
HSPCs to other cell types [1,31]. Within this niche, the endosteum
lines the inner surface of the bone and serves as the interface
between the bone and BM. Even though traditionally, bone and
BM functions have been regarded as distinct, unrelated processes,
it is becoming increasingly clear that the bone remodeling cells,
osteoblasts and osteoclasts, are crucial components of the BM
microenvironment. Osteoblasts and osteoclasts interact with each
other through cytokines secreted by either cell type, as well as by
membrane-bound ligands and receptors to initiate intracellular
signaling [3,6]. Osteoblasts and BM stromal cells secrete two
cytokines, macrophage colony stimulating factor (M-CSF) and
RANKL, which are both necessary and sufficient to induce
osteoclast differentiation. M-CSF induces the expression of RANK
in osteoclast precursor cells, priming them to differentiate in
response to RANKL [6]. In addition, osteoclasts stimulated with
M-CSF undergo cytoskeletal reorganization, cell spreading and
migration [32,33]. The downstream effects of RANKL-induced
signaling include the expression of CTSK and TRAP, genes which
encode crucial bone-resorbing enzymes that are secreted into the
BM microenvironment and stimulate mobilization of HSPCs
[6,11,12,34]. RANKL also induces expression of integrin avb3,
which plays an important role in osteoclast adhesion, migration,
and cell signaling [33,34]. Therefore, intrinsic and extrinsic
regulatory pathways converge to maintain bone and BM
homeostasis.
Despite recent studies that have recognized the importance of
osteoblasts in regulating hematopoiesis [8,9,35], we did not find
any differences in osteoblast number or function between Id1
2/2
mice and wild-type controls. However, the present study does
show the importance of Id1 during osteoclast differentiation.
Osteoclast numbers were increased in the bones of Id1
2/2 mice
and differentiation of BM monocytes to osteoclasts was increased
by Id1 deficiency, suggesting a cell-autonomous role for Id1 in
osteoclastogenesis. In addition, the absence of Id1 resulted in
increased expression of CTSK, TRAP, Oscar, and NFATc1, while
overexpression of Id1 decreased expression of these genes.
Therefore, interaction between Id1 and Mitf may normally act
to inhibit a cascade of gene expression events required for
osteoclast differentiation.
As a consequence of the increased osteoclast differentiation and
activity, we observed increased secretion of extrinsic factors, such
as CTSK, into the BM microenvironment. In keeping with a
previous report showing the potential of CTSK to cleave stem cell
regulating cytokine SCF [11], we found increased plasma levels of
SCF in Id1
2/2 mice. We propose that this alteration in the level of
secreted factors in the microenvironment directly contributed to
the increased tendency of Id1
2/2 LSK cells to enter the cell cycle,
leading to increased turnover and premature exhaustion of
HSPCs. Id1
2/2 mice reconstituted with BM overexpressing Id1
were able to reestablish the levels of HSPCs and myeloid cells
comparable to those observed in wild-type mice. Furthermore,
knockdown of CTSK in the BM of Id1
2/2 mice decreased
osteoclast function and enhanced trabecular bone formation.
Finally, our finding that transplantation of wild-type BM into
Id1
2/2 mice only partially restored the bone and hematopoietic
phenotype in these animals provides more evidence that the
intrinsic program of cells in the microenvironment integrate with
multiple extrinsic molecules and pathways needed to regulate bone
and BM homeostasis. Although the present data are highly
suggestive that Id1 can play a regulatory role in both intrinsic and
extrinsic cues necessary for maintaining a balanced microenvi-
ronment, the challenge for future investigations will be to sort out
cell intrinsic versus cell extrinsic activities in vivo. Undoubtedly this
will be a difficult task, as they are most certainly interconnected,
but by doing so it will elucidate the precise molecular mechanisms
responsible for the role of Id1 in the bone and BM.
Finally, it has been shown that Id proteins often have
overlapping functions and can compensate for each other.
Specifically, Id1 and Id3 were shown to have very similar
expression patterns and targeting of both genes is often required
to produce a phenotype [36]. Previously, we reported that tumor
growth was inhibited more effectively in Id1
+/2, Id3
2/2 than in
Id1
+/2, Id3
+/+ mice [29]. Similarly, other studies have shown that
simultaneous targeting of Id1 and Id3, compared to targeting of
each gene alone, is more effective at inhibiting tumor growth and
metastatic potential of breast, colorectal, gastric, and pancreatic
cancers [37–40]. In the current study, the absence of Id1 alone
produced a significant bone and hematopoietic phenotype,
suggesting that Id3 does not compensate for Id1 in this instance.
However, we found that Id3 expression is slightly elevated in the
BM of Id1
2/2 mice compared to wild-type littermates (data not
shown). The significance of this finding is so far unclear, but it will
be of interest to observe if Id1
2/2, Id3
+/2 mice have a more severe
bone and hematopoietic phenotype compared to Id1
2/2, Id3
+/+
mice. Clearly, more work will be necessary to elucidate the precise
role of Id3 in the bone and hematopoietic phenotypes described
here.
It is clear that our understanding of the fundamental
mechanisms underlying the connections between the bone and
BM is still in its infancy. In the future, many fruitful discoveries
may come from investigating the commonalities between these two
systems. This study offers insight into the cellular and molecular
interactions of Id1 in regulation of bone and BM physiology.
Although the clinical relevance of our findings has yet to be
determined, the knowledge acquired from our results has the
possibility of translating into potential therapeutic treatments in
the areas of osteoporotic and malignant diseases. Moreover,
microenvironments have garnered increased attention in recent
years, due to findings that highlight the importance of BM cells,
stem cells, and niches in areas of diseases such as cancer. We
previously showed the role of Id proteins in supporting the growth
of primary tumors and metastatic lesions [29,41]. We also
demonstrated the importance of niches in metastatic spread of
tumor cells [42]. From the results of the present study, it is
intriguing to speculate that long-standing osteoporosis may result
in a reduced HSC pool, thus impairing the mobilization of HSCs
to future peripheral sites of metastasis. It would also be of interest
to investigate whether cooperation between osteoclasts and
HSPCs can create a favorable environment for tumor cells to
engraft and proliferate in the bones. A better understanding of the
Id1 Regulates Bone Homeostasis
PLoS ONE | www.plosone.org 10 November 2009 | Volume 4 | Issue 11 | e7955function of Id genes in osteoclasts, hematopoietic cells, tumori-
genesis, and metastasis is clearly necessary in order to intelligently
design tailored therapies. As the molecular and cellular events that
regulate the function of the BM microenvironment are unraveled,
novel methods for its specific manipulation for tailored therapies
should also be revealed.
Materials and Methods
Mice
Generation of Id1
2/2 mice has been previously reported [43].
Animals used in all experiments were matched for sex, age (6–8
weeks old) and genetic background (C57B6/Sv129). All animal
procedures were approved and performed under the guidelines of
the Institutional Animal Care and Use Committee (IACUC).
Micro-Computed Tomography (Micro-CT)
To assess bone microarchitecture, the right femurs of the mice
were removed and cleaned of all soft tissue. The bones were
scanned in saline, using the Enhanced Vision Systems Model MS-
8 In Vitro Micro-CT Scanner (GE Healthcare). 2-D projections of
4 femurs per scan, 4 hours per scan, were collected by Evolver
software (GE Healthcare). Microview (GE Healthcare) was used to
calculate 2-D images, 3-D volume generation, and threshold
analysis.
Mechanical Testing
To assess bone strength, the left femurs of the mice were
removed and cleaned of all soft tissue. A 3-point bending test was
performed by placing the bones, anterior face up, on two supports
equidistant from the ends and 7 mm apart. The load was applied
to the center of the femoral shaft with a velocity of 0.05 mm/
second until fracture. Load displacement curves for each
individual femur were recorded and used to calculate the bending
moment (PL/4) and bending rigidity (mL3/48), where P is the
applied load, L is the span of the support points (7 mm), and m is
the slope of the linear portion of the load-displacement curve.
Osteoclast Formation and Resorption Assays
BM cells from long bones were cultured in a–minimal essential
medium (a-MEM) containing 10% fetal bovine serum (FBS),
penicillin, streptomycin, and 5 ng/mL M-CSF (PeproTech) for
16 hours. Nonadherent cells were harvested and cultured for 3
more days in the presence of 30 ng/mL M-CSF. Floating cells
were removed and adherent cells were used as osteoclast
precursors. The cells were further cultured in medium supple-
mented with 30 ng/mL M-CSF and 50 ng/mL RANKL
(PeproTech) for 3 days. The culture plate was stained for
TRAP-positive multinuclear cells (TRAP
+ MNCs) using the
leukocyte acid phosphatase (TRAP) kit (Sigma-Aldrich). TRAP
+
MNCs containing more than 3 nuclei were counted. For
resorption assays, cells were plated on BD BioCoat Osteologic
slides (BD Bioscience). After 10 days in culture in medium
supplemented with 30 ng/mL M-CSF and 50 ng/mL RANKL,
the cells were removed with bleach and resorption pits were
visualized by von Kossa staining.
Histology, Immunohistochemistry, and TRAP Staining
The femurs were cleaned of muscle and fixed in 4%
paraformaldehyde for 48 hours. Following an overnight running
water rinse, the bones were decalcified in 10% EDTA until the
bones were soft and flexible, and processed in a VIP tissue
processor to paraffin. Embedded samples were sectioned to a
thickness of 5 mm and stained for H&E for standard histology. The
following antibodies were used for immunohistochemical analysis:
Procollagen type I clone SP1.D8 (Developmental Studies Hybrid-
oma Bank, University of Iowa) and Cathepsin K clone C-16
(Santa Cruz Biotechnology). For TRAP staining, the use of
hexazonium pararosanaline for localization of acid phosphatase
activity was previously described [44]. When this acid phosphatase
method is used histochemically, in the presence of tartrate, the
resulting stain is due to TRAP activity [45]. To prevent bias, all
slides were coded and a total of 10 randomly chosen fields were
assessed for each slide. For determination of common bone
parameters, such as quantitation of cell types, determination of
bone surfaces, and mineral apposition rate, the slides were
evaluated with use of the Bioquant Morphometric System
(Bioquant Image Analysis Corp., Nashville, TN).
Bone Histomorphometry
At 5 weeks of age, each animal was labeled by intraperitoneal
injection with Tetracycline (5 mg/kg body weight), followed by
Xlenol Orange (90 mg/kg body weight) with a 4 day interval
between labels. One day after the second label, the animals were
sacrificed and the femurs were removed. The bones were
subsequently fixed in 10% neutral buffered formalin for forty-
eight hours, washed overnight in running water, dehydrated
through a graded ethanol treatment, cleared in xylene, embedded
in methyl methacrylate, and sectioned to a thickness of 5 mm, as
previously described [46]. The distance between the two labels was
measured in 10 randomly chosen fields per slide, and the mineral
apposition rate (mm/day) was determined by dividing the mean
distance between the double labels by the interlabel time (4 days).
Cell Preparation and Flow Cytometry
BM cell numbers were determined with a FACSCalibur (BD).
Red blood cells were lysed using ACK buffer (Gibco, Invitrogen)
according to the manufacturer’s instructions. For the preparation
of cells for flow cytometry, before cells were stained with specific
antibodies, nonspecific binding sites were blocked, when needed,
with purified anti-FcgRII/III (93; ebioscience). All cells were
stained at 4uC in PBS with 5% (vol/vol) FCS. The following
antibodies were used for staining: anti-CD3 (2C11), anti-CD11c
(HL3), anti-CD43 (S7; all from Pharmingen); anti-CD34 (Ram34),
anti-CD19 (1D3), anti-NK1.1 (PK136), anti-Ter119 (Ter119),
anti-Gr1 (RB6-8C5), anti-CD11b (M1/70), anti-CD16/32 (93),
anti-CD117 (2B8), anti-Sca-1 (D7), anti-CD45R (RA3-6B2), anti-
IgM (11/41) and anti-CD25 (PC61.5; all from eBioscience). The
following reagents were used for secondary steps: DAPI (4,6-
diamino-2-phenylindole; Molecular Probes) and streptavidin-
phycoerythrin-carbocyanine 5.5 (Caltag).
Differential Blood Cell Counts
Blood samples were obtained by retro-orbital bleeding and
diluted 1:4 in PBS with 2 mM EDTA, 5% BSA. Complete blood
cell counts were analyzed on an ADVIA 120 (Bayer).
Cell Cycle Analysis of Progenitor Cells
For BrdU incorporation, mice were first injected intraperitone-
ally with BrdU (1 mg per 6 g of mouse weight), followed by
administration of BrdU in the drinking water (0.8 mg/ml) for 5
days. BM cells were harvested and stained for surface markers.
Intracellular staining with anti-BrdU (PE) was carried out using
the BrdU Flow Kit (BD Pharmingen) following the manufacturer’s
instructions. Sca-1 and c-kit antibodies were used as stem cell
surface markers. For assessing in vitro proliferation, Lin
2, Sca-1
+,c -
kit
+ (LSK) stem cells were sorted from the BM into a 48 well plate
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manual cell counting under the microscope. Cells were cultured in
StemSpan Serum Free Expansion Medium (STEMCELL Tech-
nologies) containing StemSpan CC100 Cytokine Cocktail
(100 ng/ml SCF, 100 ng/ml Flt-3, 20 ng/ml IL-3, 20 ng/ml IL-
6) (STEMCELL Technologies).
Quantitative PCR (qPCR)
Femurs were frozen in liquid nitrogen and crushed with a
mortar and pestle. RNA from the crushed bone was extracted
using the RNAqueous kit (Ambion), and reverse transcribed using
Superscript III reverse transcriptase (Invitrogen). QPCR was
performed on a 7500 Fast Real Time PCR System (Applied
Biosystems), using TaqMan Universal PCR Master Mix (Applied
Biosystems). Relative expression was normalized to b-actin levels.
SCF ELISA
Plasma levels of SCF were determined using the Mouse SCF
Quantikine ELISA kit (R&D systems) according to manufacturer’s
instructions.
5-FU Challenge
Mice were injected intraperitoneally with 150 mg/kg 5-FU in
PBS once a week.
Bone Marrow Transplantation
Recipient mice were lethally irradiated with a single dose of
9.5 Gy of whole-body irradiation. 24 hours after irradiation,
2610
6 donor lineage depleted BM cells were injected by tail vein.
The BM of donor mice was harvested by flushing femurs and
tibias with PBS+2% FBS. Lineage negative cells were purified by
lineage-marker negative selection using the Mouse Hematopoietic
Progenitor Enrichment kit (StemCell Technologies). All recipient
mice were female and all donor mice were male.
Plasmids
PGEW-empty and PGEW-Id1 vectors were built from plasmid
pCCL.sin.cPPT.PGK.GFP.WPRE [47]. A linker was inserted
downstream of GFP for the purpose of introducing restriction sites
for the insertion of the EF1a promoter and Id1. The EF1a
promoter fragment (21208 to 224) was inserted into the PshAI
site of pCCL.sin.cPPT.PGK.GFP.linker.WPRE to generate the
pCCL.sin.cPPT.PGK.GFP.EF1a.linker.WPRE vector, which we
have termed PGEW-empty for simplicity. A 585-bp fragment
containing the complete coding sequence of Id1 was obtained by
PCR, using cDNA from mouse BM as a template, with
oligonucleotide primers (59-CGGAATTCCTCCGCCTGTTCT-
CAGGA-39 and 59-CAAGAAGCTTGCGGTAGTGTCTTT-
CC-39). The fragment was digested with EcoRI, blunted with
T4 DNA Polymerase, and lastly, digested with SalI. This fragment
was then inserted into the PmeI/SalI sites of pCCL.sin.cPPT.
PGK.GFP.EF1a.linker.WPRE to generate the pCCL.sin.cPPT.
PGK.GFP.EF1a.ID1.WPRE vector, which we have termed
PGEW-Id1 for simplicity. shCTSK (pLKO.1-puro short hairpin
Ctsk, TRCN0000054626) and control shGFP were purchased
(Sigma-Aldrich).
Vector Production and Titration
Lentiviral vector stocks, pseudotyped with the vesicular
stomatitis G protein (VSV-G), were produced by transient
cotransfection of 293T cells and titered on HeLa cells as described
[47]. Viral supernatants were concentrated to titers $10
8
transduction units/ml by ultracentrifugation.
Isolation and Transduction of Hematopoietic Cells
BM of donor mice was harvested by flushing femurs and tibias
with PBS+2% FBS. Lin
2 cells were purified by lineage-marker
negative selection using the Mouse Hematopoietic Progenitor
Enrichment kit (StemCell Technologies), plated at a density of
1610
6 cells/ml in StemSpan Serum Free Expansion Medium
(STEMCELL Technologies). Lin
2 cells were transduced with
concentrated virus for 12 h (MOI of 50–60), washed, and
resuspended in PBS for transplantation.
Statistical Analysis
Statistical and graphical analyses were performed using
GraphPad Prism software (version 3.0). The data was analyzed
using Student’s unpaired t-test and results were considered
significant at the 95% significance level (P,0.05). Results were
representative of two or more independent experiments, and data
was expressed as mean 6 SEM of at least 3 replicates.
Supporting Information
Figure S1 Id1
2/2 mice weigh less and have less trabecular bone.
(A) Weights of 6-week old wild-type and Id1
2/2 mice
(***P,0.001; n=12). Error bars represent6S.E.M. (B) Represen-
tative H&E staining of femoral sections from wild-type and Id1
2/2
mice. Arrowheads indicate areas of trabecular bone; M, marrow;
GP, growth plate.
Found at: doi:10.1371/journal.pone.0007955.s001 (2.17 MB PPT)
Figure S2 Absence of Id1 does not alter the expression of
osteoblast-associated genes. Results of qPCR for the expression of
RANKL, OPG, and SDF-1 in the BM of wild-type and Id1
2/2
mice (n=6). Error bars represent 6S.E.M.
Found at: doi:10.1371/journal.pone.0007955.s002 (0.04 MB PPT)
Figure S3 Detection of Y chromosome DNA sequences in BM
transplanted mice. DNA samples were isolated from 200 mLo f
peripheral blood from lethally irradiated wild-type and Id1
2/2
mice that were transplanted with either wild-type or Id1
2/2 BM.
Control DNA was isolated from wild-type male and female mice,
and admixed to generate standards with known ratios of male and
female DNA. Thus, XY male DNA was serially diluted in XX
female DNA. Standards and samples were assayed by using
TaqMan Gene Expression Assays (Applied Biosystems) for the sex
determining region (SRY) gene. The cycle threshold (Ct) readings
of the standards were used to generate a standard curve by plotting
the mean of triplicate Ct values versus the log of the percentage of
Y DNA in the background of XX DNA and calculating a
regression line. The amount of Y DNA in unknown samples was
determined by applying the mean Ct value of triplicates to the
standard curve and correcting for the total amount of DNA in the
sample to determine the percentage of male sequence within a
female background. Error bars represent 6S.E.M.
Found at: doi:10.1371/journal.pone.0007955.s003 (0.04 MB PPT)
Figure S4 Absence of Id1 specifically upregulates the expression
of CTSK and not other cathepsins. Results of qPCR for the
expression of other cathepsin family genes, CTSL and CTSB in
the BM of wild-type and Id1
2/2 mice (n=6). Error bars
represent 6S.E.M.
Found at: doi:10.1371/journal.pone.0007955.s004 (0.04 MB PPT)
Figure S5 A model for the role of Id1 in regulating myeloid and
osteoclast differentiation. Id1 inhibition of myeloid and osteoclast
differentiation regulates HSC niche factors and limits HSC
mobilization (left). In the absence of Id1, osteoclast differentiation
increases and results in increased CTSK secretion (right).
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Figure S6 Use of lentiviral vectors for the overexpression of Id1.
(A) Schematic drawings of the lentiviral vector containing Id1
(PGEW-Id1) and the empty vector control (PGEW-empty). Both
vectors contain the promoter of the elongation factor 1 alpha
(EF1a) gene and carry an internal cassette for the enhanced green
fluorescent protein (EGFP) driven by the promoter of the human
phosphoglycerate kinase (PGK) gene. The following viral cis-
acting sequences are labeled: long terminal regions (LTR); major
splice donor sites (SD), encapsidation signal (y) including the 59
portion of the gag gene (GA); Rev-response element (RRE); splice
acceptor sites (SA); and post-transcriptional regulatory element of
woodchuck hepatitis virus (Wpre). (B) Expression of Id1 in the BM
of transplanted mice (***P,0.001; n=6). Lin- BM cells from
Id1
2/2 mice were transduced with lentivirus containing PGEW-
Id1 or PGEW-empty vector overnight and transplanted into
lethally irradiated Id1
2/2 mice. After 8 weeks, the mice were
sacrificed and BM from the femur was collected for qPCR
analysis. Error bars represent 6S.E.M.
Found at: doi:10.1371/journal.pone.0007955.s006 (0.05 MB PPT)
Figure S7 Use of lentiviral vectors to knockdown expression of
CTSK. (A) Expression of CTSK in the BM of transplanted mice
(***P,0.001; n=6). Lin- BM cells from Id1
2/2 mice were
transduced with lentivirus containing shCTSK or shGFP vector
overnight and transplanted into lethally irradiated Id1
2/2 mice.
After 3.5 months, the mice were sacrificed and BM from the femur
was collected for qPCR analysis. Error bars represent 6S.E.M. (B)
Representative H&E staining of femoral sections from Id1
2/2
mice transplanted with BM containing a shRNA targeted against
CTSK or GFP. Arrowheads indicate areas of trabecular bone; M,
marrow; GP, growth plate.
Found at: doi:10.1371/journal.pone.0007955.s007 (1.85 MB PPT)
Table S1 Steady state peripheral blood cell counts in wild-type
and Id1
2/2 mice.
Found at: doi:10.1371/journal.pone.0007955.s008 (0.06 MB PPT)
Table S2 Characteristics of femurs in CTSK-shRNA and GFP-
shRNA BM transplanted mice.
Found at: doi:10.1371/journal.pone.0007955.s009 (0.05 MB PPT)
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